Header Logo

Connection

Gary Holland to CD4 Lymphocyte Count

This is a "connection" page, showing publications Gary Holland has written about CD4 Lymphocyte Count.
Connection Strength

0.721
  1. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000). Am J Ophthalmol. 2008 Jan; 145(1):12-22.
    View in: PubMed
    Score: 0.068
  2. Decreased macular leukocyte velocity in human immunodeficiency virus-infected individuals. Am J Ophthalmol. 2001 Nov; 132(5):711-9.
    View in: PubMed
    Score: 0.045
  3. Ischemic maculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol. 2001 Nov; 132(5):727-33.
    View in: PubMed
    Score: 0.045
  4. Immune recovery uveitis. Am J Ophthalmol. 2000 Jul; 130(1):103-6.
    View in: PubMed
    Score: 0.041
  5. Contralateral Eye Involvement and Retinal Detachment in Patients with Cytomegalovirus Retinitis Treated with Intravitreous Ganciclovir. Ocul Immunol Inflamm. 2021 Aug 18; 29(6):1145-1150.
    View in: PubMed
    Score: 0.040
  6. Quantitative cytomegalovirus DNA level in the blood and its relationship to cytomegalovirus retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 1999 Jan; 106(1):133-41.
    View in: PubMed
    Score: 0.037
  7. Active cytomegalovirus retinitis after the start of antiretroviral therapy. Br J Ophthalmol. 2019 02; 103(2):157-160.
    View in: PubMed
    Score: 0.036
  8. Uveitis associated with human immunodeficiency virus infection. Am J Ophthalmol. 1998 Mar; 125(3):301-5.
    View in: PubMed
    Score: 0.035
  9. Chronic multifocal retinal infiltrates in patients infected with human immunodeficiency virus. Am J Ophthalmol. 1998 Mar; 125(3):312-24.
    View in: PubMed
    Score: 0.035
  10. Cytomegalovirus Retinitis in Patients With Acquired Immunodeficiency Syndrome After Initiating Antiretroviral Therapy. Am J Ophthalmol. 2017 Feb; 174:23-32.
    View in: PubMed
    Score: 0.032
  11. Risk factors for CMV retinitis among individuals with HIV and low CD4 count in northern Thailand: importance of access to healthcare. Br J Ophthalmol. 2016 08; 100(8):1017-21.
    View in: PubMed
    Score: 0.031
  12. Incidence and long-term outcomes of the human immunodeficiency virus neuroretinal disorder in patients with AIDS. Ophthalmology. 2015 Apr; 122(4):760-8.
    View in: PubMed
    Score: 0.028
  13. Uveitis in human immunodeficiency virus-infected persons with CD4+ T-lymphocyte count over 200 cells/mL. Clin Exp Ophthalmol. 2014 Mar; 42(2):118-25.
    View in: PubMed
    Score: 0.025
  14. Didanosine-associated retinal toxicity in adults infected with human immunodeficiency virus. JAMA Ophthalmol. 2013 Feb; 131(2):255-9.
    View in: PubMed
    Score: 0.024
  15. Association between retinal nerve fiber layer thickness and abnormalities of vision in people with human immunodeficiency virus infection. Am J Ophthalmol. 2012 Apr; 153(4):734-42, 742.e1.
    View in: PubMed
    Score: 0.023
  16. Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with visual function. Am J Ophthalmol. 2012 Mar; 153(3):428-433.e1.
    View in: PubMed
    Score: 0.022
  17. Retinal vessel caliber among people with acquired immunodeficiency syndrome: relationships with disease-associated factors and mortality. Am J Ophthalmol. 2012 Mar; 153(3):434-444.e1.
    View in: PubMed
    Score: 0.022
  18. Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group. Am J Ophthalmol. 2008 Mar; 145(3):453-462.
    View in: PubMed
    Score: 0.017
  19. Hemorheologic abnormalities associated with HIV infection: altered erythrocyte aggregation and deformability. Invest Ophthalmol Vis Sci. 2006 Sep; 47(9):3927-32.
    View in: PubMed
    Score: 0.016
  20. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology. 2006 Apr; 113(4):684-94.
    View in: PubMed
    Score: 0.015
  21. The safety of discontinuation of maintenance therapy for cytomegalovirus (CMV) retinitis and incidence of immune recovery uveitis following potent antiretroviral therapy. HIV Clin Trials. 2005 May-Jun; 6(3):136-46.
    View in: PubMed
    Score: 0.014
  22. Posterior intracorneal opacities in patients with HIV infection. Ocul Immunol Inflamm. 2005 Feb; 13(1):25-31.
    View in: PubMed
    Score: 0.014
  23. An assessment of polymorphonuclear leukocyte rigidity in HIV-infected individuals after immune recovery. Invest Ophthalmol Vis Sci. 2002 Jun; 43(6):1857-61.
    View in: PubMed
    Score: 0.012
  24. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy. J Infect Dis. 2001 May 01; 183(9):1399-404.
    View in: PubMed
    Score: 0.011
  25. Increased polymorphonuclear leucocyte rigidity in HIV infected individuals. Br J Ophthalmol. 2000 Jul; 84(7):727-31.
    View in: PubMed
    Score: 0.010
  26. Chronic varicella-zoster virus epithelial keratitis in patients with acquired immunodeficiency syndrome. Arch Ophthalmol. 1998 Aug; 116(8):1011-7.
    View in: PubMed
    Score: 0.009
  27. Transient vitreous inflammatory reactions associated with combination antiretroviral therapy in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 1998 Mar; 125(3):292-300.
    View in: PubMed
    Score: 0.009
  28. A randomized, double-blind trial of valaciclovir prophylaxis for cytomegalovirus disease in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophylaxis Study Group. J Infect Dis. 1998 Jan; 177(1):48-56.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.